Kou Yuying, Xu Yanxia, Xue Ming, Ruan Jinxiu, Zhang Zhenqing, Liu Keliang
Department of Pharmacology, School of Chemical Biology and Pharmaceutical Sciences, Capital University of Medical Sciences, Beijing 100069, PR China.
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Dec 15;828(1-2):75-9. doi: 10.1016/j.jchromb.2005.09.028. Epub 2005 Oct 11.
A sensitive and specific high-performance liquid chromatographic assay with electrospray ionization mass spectrometry detection (LC-ESI-MS) has been developed and validated for the identification and quantification of the novel anticholinergic drug phencynonate in rat blood and urine. The sample pretreatment involves basification and iterative liquid-liquid extraction with ethyl ether-dichloromethane (2:1, v/v) solution, followed by LC separation and positive electrospray ionization mass spectrometry detection. The chromatography was on BetaBasic-18 column (150 mm x 2.1mm i.d., 3 microm). The mobile phase was composed of methanol-water (85:15, v/v), containing 0.5 per thousand formic acid, which was pumped at a flow-rate of 0.2 ml/min. Thiencynonate was selected as the internal standard (IS). Simultaneous MS detection of phencynonate and IS was performed at m/z 358.4 (phencynonate), m/z 364 (thiencynonate), and the selected reaction ion monitoring (SRM) of the two compounds was at 156. Phencynonate eluted at approximately 5.25 min, thiencynonate eluted at approximately 5.10 min and no endogenous materials interfered with their measurement. Linearity was obtained over the concentration range of 1-100 ng/ml in rat blood and 1-500 ng/ml in rat urine. The lower limit of quantification (LLOQ) was reproducible at 1 ng/ml in both of rat blood and urine. The precision measured was obtained from 2.92 to 9.76% in rat blood and 4.17 to 9.76% in rat urine. Extraction recoveries were in the range of 69.57-79.49% in blood and 56.85-64.86% in urine. This method was successfully applied to the identification and quantification of phencynonate in pharmacokinetic studies.
已开发并验证了一种灵敏且特异的高效液相色谱法,结合电喷雾电离质谱检测(LC-ESI-MS),用于鉴定和定量大鼠血液和尿液中的新型抗胆碱能药物苯环壬酯。样品预处理包括碱化以及用乙醚-二氯甲烷(2:1,v/v)溶液进行反复液-液萃取,随后进行液相色谱分离和正电喷雾电离质谱检测。色谱分析在BetaBasic-18柱(150 mm×2.1mm内径,3微米)上进行。流动相由甲醇-水(85:15,v/v)组成,含有0.5‰的甲酸,以0.2 ml/min的流速泵送。选择噻环壬酯作为内标(IS)。在m/z 358.4(苯环壬酯)、m/z 364(噻环壬酯)处同时进行苯环壬酯和内标的质谱检测,两种化合物的选择反应离子监测(SRM)在156。苯环壬酯在约5.25分钟洗脱,噻环壬酯在约5.10分钟洗脱,且无内源性物质干扰其测定。在大鼠血液中1-100 ng/ml以及大鼠尿液中1-500 ng/ml的浓度范围内获得线性关系。大鼠血液和尿液中的定量下限(LLOQ)均能在1 ng/ml时重现。测得的精密度在大鼠血液中为2.92%至9.76%之间,在大鼠尿液中为4.17%至9.76%之间。血液中的萃取回收率在69.57 - 79.49%范围内,尿液中的萃取回收率在56.85 - 64.86%范围内。该方法已成功应用于药代动力学研究中苯环壬酯的鉴定和定量。